Advertisement

Topics

Asahi Kasei Corporation Company Profile

17:18 EST 10th December 2018 | BioPortfolio

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. On October 1, 2003, all core operations were transferred to seven wholly owned constituent corporations as autonomous operating business units. Asahi Kasei Corporation, as the parent company, functions as a holding company for group operations. An Independent Businesses Group not included in the constituent corporations provides group services

Location

535 Madison Avenue, 33rd Floor
New York
New York
10022
United States of America

Contact

Phone: 1-212-371-9900
Fax: 1-212-371-9050
Email: extech@om.asahi-kasei.co.jp


News Articles [127 Associated News Articles listed on BioPortfolio]

ZOLL Defeats Claims by AutoMedx, Awarded Damages and Attorneys’ Fees

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that it was awarded $1.8 million in dama...

FDA provides updates on wearable cardioverter defibrillator recall

Asahi Kasei subsidiary Zoll Medical has updated customer training for the proper use of its LifeVest 4000 wearable cardiovert -More- 

ZOLL Heroes for Life Program Recognizes Everyday People Making a Difference with ZOLL AEDs

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that it is launching a Heroes for Life...

Artisan Draws Strength from Japan and the US to Treat Sepsis

Filmed at the BIO conference in San Diego, Fintan Walton talks to President and Chief Executive Officer of Artisan Pharma, Jeffrey D. Wager MD. Dr Jeffrey reveals how building close, long term relat...

Global Polycarbonates Market Segmented by Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global polycarbonates market has been estimated at USD 13,720.95 million in 2017. The market is expected to register a CAGR of 5.46% during the forecast period, 2018 to 2023. Electrical and electr...

Global Polycarbonates Market Segmented by Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global polycarbonates market has been estimated at USD 13,720.95 million in 2017. The market is expected to register a CAGR of 5.46% during the forecast period, 2018 to 2023. Electrical and electr...

2018 Top 5 Ionexchange Membrane Electrolyzer Players in North America, Europe, AsiaPacific, South America, Middle East and Africa [Report Updated: 06062018] Prices from USD $4960

Iron exchange membrane electrolyzer IEM electrolyzer mainly by the anode, cathode, ion exchange membrane, electrolytic cell frame and conductive copper rods and other components, each cell by a number...

Global Engineering Plastics Market Segmented by Product Type, Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1941

The global engineering plastics market has been estimated at USD 89,893.90 million in 2017. The market is expected to register a CAGR of 4.99% during the forecast period, 2018 to 2023. PET dominated t...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Light scattering properties of self-organized nanostructured substrates for thin-film solar cells.

We investigate the scattering properties of a novel kind of nano-textured substrates, fabricated in a self-organized fashion by defocused ion beam sputtering. These substrates provide strong and broad...

Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study.

Limited study has detailed the procedural outcomes and utilization of contemporary coronary guidewires and microcatheters designed for chronic total occlusion (CTO) percutaneous revascularization and ...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Asahi ViE Dialyzer in Canada

The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .

SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke

The objective of this study is to obtain post market data on the Asahi Chikai Black 18 neurovascular guidewire in the treatment of intracranial large vessel occlusive stroke. This will be ...

The Effect of Vitamin E-coated Polysulfone Membrane on Oxidative Stress, Inflammation and Monocytes in Critically Ill Patients in CRRT

The study evaluate the effect of a membrane in polysulfone covered with vitamin E (ViE15-A, ASAHI Kasey, Tokyo, Japan) versus non-vitamin E polysulfone membrane (REXEED-15A, ASAHI Kasey, T...

Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients

The main purpose of this longitudinal study is to point out the effect of VitabranE on the ESA resistance and on the anemia observed in HD patients undergoing EPO maintenance therapy. As ...

Companies [186 Associated Companies listed on BioPortfolio]

Asahi Kasei Pharma Corp.

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Pharma America

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) ...

Rakuto Kasei Ltd

Rakuto Kasei(Israel) Ltd. was established in 1990 as a joint venture with Rakuto Kasei Industrial Co. Japan, a leading worldwide producer of enzymes. Based on over 20 years of experience in the field ...

More Information about "Asahi Kasei Corporation" on BioPortfolio

We have published hundreds of Asahi Kasei Corporation news stories on BioPortfolio along with dozens of Asahi Kasei Corporation Clinical Trials and PubMed Articles about Asahi Kasei Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asahi Kasei Corporation Companies in our database. You can also find out about relevant Asahi Kasei Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record